Article
Licensed
Unlicensed
Requires Authentication
Bone Mineral Density and Body Composition and Influencing Factors in Children with Rheumatic Diseases Treated with Corticosteroids
-
D. Mul,
Published/Copyright:
February 1, 2002
Published Online: 2002-02
©2011 by Walter de Gruyter GmbH & Co.
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- TABLE OF CONTENTS
- EDITORIAL
- Deteriorating Diabetes Control during Adolescence: Physiological or Psychosocial?
- How Should the Short Stature of Girls with Turner's Syndrome be Treated?
- Favorable Final Height Outcome in Girls with Ullrich-Turner Syndrome Treated with Low-Dose Growth Hormone Together with Oxandrolone Despite Starting Treatment After 10 Years of Age
- SHOX Intragenic Microsatellite Analysis in Patients with Short Stature
- Auxological Computer Based Network for Early Detection of Disorders of Growth and Weight Attainment
- Microadenomas of the Pituitary Gland in Children With and Without Hypophyseal Dysfunction in Magnetic Resonance Imaging
- Pamidronate Treatment of Osteogenesis Imperfecta - Lack of Correlation Between Clinical Severity, Age at Onset of Treatment, Predicted Collagen Mutation and Treatment Response
- The Relationship between Clinical Severity of Noonan's Syndrome and Growth, Growth Hormone (GH) Secretion and Response to GH Treatment
- Cardiac Mass and Function, Carotid Artery Intima-Media Thickness and Lipoprotein (a) Levels in Children and Adolescents with Type I Diabetes Mellitus of Short Duration
- Bone Mineral Density and Body Composition and Influencing Factors in Children with Rheumatic Diseases Treated with Corticosteroids
- Tumor Necrosis Factor-α Levels in Short Children
- Reference Values for Morning Salivary Cortisol Concentrations in Healthy School-aged Children
- Impaired Glucose Homeostasis in Young Adult Thalassemic Patients: A Pilot Study with Acarbose
- An Activating Mutation of the Thyrotropin Receptor Gene in Hereditary Non-Autoimmune Hyperthyroidism
- Growth Hormone Therapy May Increase Fracture Risk in a Pubertal Patient with Osteogenesis Imperfecta
- Hypogonadotrophic Hypogonadism Associated with Prelingual Deafness due to a Connexin 26 Gene Mutation
- BOOK REVIEWS. CALENDAR
Articles in the same Issue
- TABLE OF CONTENTS
- EDITORIAL
- Deteriorating Diabetes Control during Adolescence: Physiological or Psychosocial?
- How Should the Short Stature of Girls with Turner's Syndrome be Treated?
- Favorable Final Height Outcome in Girls with Ullrich-Turner Syndrome Treated with Low-Dose Growth Hormone Together with Oxandrolone Despite Starting Treatment After 10 Years of Age
- SHOX Intragenic Microsatellite Analysis in Patients with Short Stature
- Auxological Computer Based Network for Early Detection of Disorders of Growth and Weight Attainment
- Microadenomas of the Pituitary Gland in Children With and Without Hypophyseal Dysfunction in Magnetic Resonance Imaging
- Pamidronate Treatment of Osteogenesis Imperfecta - Lack of Correlation Between Clinical Severity, Age at Onset of Treatment, Predicted Collagen Mutation and Treatment Response
- The Relationship between Clinical Severity of Noonan's Syndrome and Growth, Growth Hormone (GH) Secretion and Response to GH Treatment
- Cardiac Mass and Function, Carotid Artery Intima-Media Thickness and Lipoprotein (a) Levels in Children and Adolescents with Type I Diabetes Mellitus of Short Duration
- Bone Mineral Density and Body Composition and Influencing Factors in Children with Rheumatic Diseases Treated with Corticosteroids
- Tumor Necrosis Factor-α Levels in Short Children
- Reference Values for Morning Salivary Cortisol Concentrations in Healthy School-aged Children
- Impaired Glucose Homeostasis in Young Adult Thalassemic Patients: A Pilot Study with Acarbose
- An Activating Mutation of the Thyrotropin Receptor Gene in Hereditary Non-Autoimmune Hyperthyroidism
- Growth Hormone Therapy May Increase Fracture Risk in a Pubertal Patient with Osteogenesis Imperfecta
- Hypogonadotrophic Hypogonadism Associated with Prelingual Deafness due to a Connexin 26 Gene Mutation
- BOOK REVIEWS. CALENDAR
